We are analyzing https://link.springer.com/article/10.1007/s13277-013-0756-5.

Title:
Effects of Rab27a on proliferation, invasion, and anti-apoptosis in human glioma cell | Tumor Biology
Description:
This study aims to investigate the relationship between Rab27a and the characteristics of glioma cell U251 such as proliferation, apoptosis, and invasion and to provide an experimental basis for future therapy in human glioma. Recombinant plasmid of pcDNA3.1-Rab27a was constructed and transfected into U251 cells with the help of Lipofectamine™2000. The expression of Rab27a was detected by Western blot. Cell viability, cell cycle, cell apoptosis, and cell migration were analyzed, respectively, by (3-(4,5)-dimethylthi-azol-2-yl)-2,5-diphenytetrazolium bromide (MTT) assay, flow cytometry, and Transwell invasion chamber methods. Meanwhile, the effect of Rab27a on secretion of cathepsin D in U251 cells was also examined. With the help of luciferase reporter assay system, the relationship between miR-124 and gene Rab27a expression was explored. Western blot showed that the expression of Rab27a was significantly increased in pcDNA3.1-Rab27a transfection group (p < 0.01) and that was significantly decreased in Rab27a-shRNA transfection group (p < 0.01) compared with control group. MTT assay, flow cytometry, and Transwell invasion chamber experiment indicated that cell viability (p < 0.01), proliferation index (p < 0.05), and invasion ability (p < 0.01) were improved significantly in pcDNA3.1-Rab27a transfection group compared with control group and that cell viability (p < 0.01), proliferation index (p < 0.05), and invasion ability (p < 0.01) were reduced markedly in Rab27a-shRNA transfection group compared with control group. The apoptosis analysis by flow cytometry demonstrated that the ratio of apoptosis in pcDNA3.1-Rab27a transfection group was significantly lower than that in control group (p < 0.05) and the ratio was notably higher in Rab27a-shRNAtransfection group than that in the control group. Cathepsin D activity assay indicated that the release of cathepsin D was enhanced in pcDNA3.1-Rab27a transfection group compared to that in the control group (p < 0.05). Rab27a could increase the glioma cell ability, promote proliferation and invasion, and suppress cell apoptosis. The above-stated effects of Rab27a possibly were exerted by increasing the secretion of cathepsin D and regulated by miR-124. In addition, the inhibition of expression of Rab27a perhaps benefited the therapy for glioma patients.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Social Networks
Telecommunications

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

article, google, scholar, pubmed, cas, cell, glioma, raba, invasion, cancer, group, cells, cathepsin, tumor, proliferation, chen, expression, rab, apoptosis, control, gtpases, zhang, wang, biol, human, transfection, access, vesicle, privacy, cookies, content, pcdnaraba, assay, review, mol, role, protein, membrane, publish, research, search, effects, migration, secretion, significantly, compared, targeting, progression, sci, traffic,

Topics {✒️}

month download article/chapter glioma cells adhesion rab27a supports exosome-dependent small gtp-binding protein rab-mediated vesicle targeting rab27a-shrna transfection group human glioma cell high-grade adult gliomas related subjects full article pdf pancreatic beta cells behav brain res privacy choices/manage cookies high-grade glioma glioma cell u251 glioma cell ability suppress cell apoptosis rab21 inhibits proliferation breast cancer growth mol med report gene rab27a expression natl cancer inst mol cancer res human glioma malignant glioma aggressiveness curr pharm biotechnol eukaryotic endomembrane system van den broecke breast cancer microenvironment rho gtpase modulation methylation-mediated silencing ire1alpha-mediated cleavage article wu 1-rab27a transfection group rab protein evolution european economic area dimethylthi-azol-2-yl discriminating radiation necrosis transmembrane protein cargo protein interaction cascades growth factor-ii folia histochem cytobiol clinical efficacy predicted patient educ couns recent technical advances trends endocrinol metab lopez-guerrero ja small gtpase rab27a pro-metastatic phenotype benign prostatic epithelium

Questions {❓}

Discriminating radiation necrosis from tumor progression in gliomas: a systematic review what is the best imaging modality?
Systematic review and meta-analysis of temozolomide in animal models of glioma: was clinical efficacy predicted?
The dilemma: does tissue expression of cathepsin D reflect tumor malignancy?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Effects of Rab27a on proliferation, invasion, and anti-apoptosis in human glioma cell
         description:This study aims to investigate the relationship between Rab27a and the characteristics of glioma cell U251 such as proliferation, apoptosis, and invasion and to provide an experimental basis for future therapy in human glioma. Recombinant plasmid of pcDNA3.1-Rab27a was constructed and transfected into U251 cells with the help of Lipofectamine™2000. The expression of Rab27a was detected by Western blot. Cell viability, cell cycle, cell apoptosis, and cell migration were analyzed, respectively, by (3-(4,5)-dimethylthi-azol-2-yl)-2,5-diphenytetrazolium bromide (MTT) assay, flow cytometry, and Transwell invasion chamber methods. Meanwhile, the effect of Rab27a on secretion of cathepsin D in U251 cells was also examined. With the help of luciferase reporter assay system, the relationship between miR-124 and gene Rab27a expression was explored. Western blot showed that the expression of Rab27a was significantly increased in pcDNA3.1-Rab27a transfection group (p < 0.01) and that was significantly decreased in Rab27a-shRNA transfection group (p < 0.01) compared with control group. MTT assay, flow cytometry, and Transwell invasion chamber experiment indicated that cell viability (p < 0.01), proliferation index (p < 0.05), and invasion ability (p < 0.01) were improved significantly in pcDNA3.1-Rab27a transfection group compared with control group and that cell viability (p < 0.01), proliferation index (p < 0.05), and invasion ability (p < 0.01) were reduced markedly in Rab27a-shRNA transfection group compared with control group. The apoptosis analysis by flow cytometry demonstrated that the ratio of apoptosis in pcDNA3.1-Rab27a transfection group was significantly lower than that in control group (p < 0.05) and the ratio was notably higher in Rab27a-shRNAtransfection group than that in the control group. Cathepsin D activity assay indicated that the release of cathepsin D was enhanced in pcDNA3.1-Rab27a transfection group compared to that in the control group (p < 0.05). Rab27a could increase the glioma cell ability, promote proliferation and invasion, and suppress cell apoptosis. The above-stated effects of Rab27a possibly were exerted by increasing the secretion of cathepsin D and regulated by miR-124. In addition, the inhibition of expression of Rab27a perhaps benefited the therapy for glioma patients.
         datePublished:2013-04-04T00:00:00Z
         dateModified:2013-04-04T00:00:00Z
         pageStart:2195
         pageEnd:2203
         sameAs:https://doi.org/10.1007/s13277-013-0756-5
         keywords:
            Rab27a
            Glioma
            Proliferation
            Apoptosis
            Cathepsin D
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0756-5/MediaObjects/13277_2013_756_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0756-5/MediaObjects/13277_2013_756_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0756-5/MediaObjects/13277_2013_756_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0756-5/MediaObjects/13277_2013_756_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0756-5/MediaObjects/13277_2013_756_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0756-5/MediaObjects/13277_2013_756_Fig6_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0756-5/MediaObjects/13277_2013_756_Fig7_HTML.gif
         isPartOf:
            name:Tumor Biology
            issn:
               1423-0380
               1010-4283
            volumeNumber:34
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Xiuwei Wu
               affiliation:
                     name:The Second Affiliated Hospital of Anhui Medical University
                     address:
                        name:Department of Medical Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anla Hu
               affiliation:
                     name:Anhui Medical University
                     address:
                        name:Department of Nutrition and Food Hygiene, School of Public Health, Anhui Medical University, Hefei, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mingjun Zhang
               affiliation:
                     name:The Second Affiliated Hospital of Anhui Medical University
                     address:
                        name:Department of Medical Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhendong Chen
               affiliation:
                     name:The Second Affiliated Hospital of Anhui Medical University
                     address:
                        name:Department of Medical Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Effects of Rab27a on proliferation, invasion, and anti-apoptosis in human glioma cell
      description:This study aims to investigate the relationship between Rab27a and the characteristics of glioma cell U251 such as proliferation, apoptosis, and invasion and to provide an experimental basis for future therapy in human glioma. Recombinant plasmid of pcDNA3.1-Rab27a was constructed and transfected into U251 cells with the help of Lipofectamine™2000. The expression of Rab27a was detected by Western blot. Cell viability, cell cycle, cell apoptosis, and cell migration were analyzed, respectively, by (3-(4,5)-dimethylthi-azol-2-yl)-2,5-diphenytetrazolium bromide (MTT) assay, flow cytometry, and Transwell invasion chamber methods. Meanwhile, the effect of Rab27a on secretion of cathepsin D in U251 cells was also examined. With the help of luciferase reporter assay system, the relationship between miR-124 and gene Rab27a expression was explored. Western blot showed that the expression of Rab27a was significantly increased in pcDNA3.1-Rab27a transfection group (p < 0.01) and that was significantly decreased in Rab27a-shRNA transfection group (p < 0.01) compared with control group. MTT assay, flow cytometry, and Transwell invasion chamber experiment indicated that cell viability (p < 0.01), proliferation index (p < 0.05), and invasion ability (p < 0.01) were improved significantly in pcDNA3.1-Rab27a transfection group compared with control group and that cell viability (p < 0.01), proliferation index (p < 0.05), and invasion ability (p < 0.01) were reduced markedly in Rab27a-shRNA transfection group compared with control group. The apoptosis analysis by flow cytometry demonstrated that the ratio of apoptosis in pcDNA3.1-Rab27a transfection group was significantly lower than that in control group (p < 0.05) and the ratio was notably higher in Rab27a-shRNAtransfection group than that in the control group. Cathepsin D activity assay indicated that the release of cathepsin D was enhanced in pcDNA3.1-Rab27a transfection group compared to that in the control group (p < 0.05). Rab27a could increase the glioma cell ability, promote proliferation and invasion, and suppress cell apoptosis. The above-stated effects of Rab27a possibly were exerted by increasing the secretion of cathepsin D and regulated by miR-124. In addition, the inhibition of expression of Rab27a perhaps benefited the therapy for glioma patients.
      datePublished:2013-04-04T00:00:00Z
      dateModified:2013-04-04T00:00:00Z
      pageStart:2195
      pageEnd:2203
      sameAs:https://doi.org/10.1007/s13277-013-0756-5
      keywords:
         Rab27a
         Glioma
         Proliferation
         Apoptosis
         Cathepsin D
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0756-5/MediaObjects/13277_2013_756_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0756-5/MediaObjects/13277_2013_756_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0756-5/MediaObjects/13277_2013_756_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0756-5/MediaObjects/13277_2013_756_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0756-5/MediaObjects/13277_2013_756_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0756-5/MediaObjects/13277_2013_756_Fig6_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0756-5/MediaObjects/13277_2013_756_Fig7_HTML.gif
      isPartOf:
         name:Tumor Biology
         issn:
            1423-0380
            1010-4283
         volumeNumber:34
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Xiuwei Wu
            affiliation:
                  name:The Second Affiliated Hospital of Anhui Medical University
                  address:
                     name:Department of Medical Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anla Hu
            affiliation:
                  name:Anhui Medical University
                  address:
                     name:Department of Nutrition and Food Hygiene, School of Public Health, Anhui Medical University, Hefei, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mingjun Zhang
            affiliation:
                  name:The Second Affiliated Hospital of Anhui Medical University
                  address:
                     name:Department of Medical Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhendong Chen
            affiliation:
                  name:The Second Affiliated Hospital of Anhui Medical University
                  address:
                     name:Department of Medical Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Tumor Biology
      issn:
         1423-0380
         1010-4283
      volumeNumber:34
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:The Second Affiliated Hospital of Anhui Medical University
      address:
         name:Department of Medical Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of China
         type:PostalAddress
      name:Anhui Medical University
      address:
         name:Department of Nutrition and Food Hygiene, School of Public Health, Anhui Medical University, Hefei, People’s Republic of China
         type:PostalAddress
      name:The Second Affiliated Hospital of Anhui Medical University
      address:
         name:Department of Medical Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of China
         type:PostalAddress
      name:The Second Affiliated Hospital of Anhui Medical University
      address:
         name:Department of Medical Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Xiuwei Wu
      affiliation:
            name:The Second Affiliated Hospital of Anhui Medical University
            address:
               name:Department of Medical Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Anla Hu
      affiliation:
            name:Anhui Medical University
            address:
               name:Department of Nutrition and Food Hygiene, School of Public Health, Anhui Medical University, Hefei, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Mingjun Zhang
      affiliation:
            name:The Second Affiliated Hospital of Anhui Medical University
            address:
               name:Department of Medical Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Zhendong Chen
      affiliation:
            name:The Second Affiliated Hospital of Anhui Medical University
            address:
               name:Department of Medical Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Medical Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of China
      name:Department of Nutrition and Food Hygiene, School of Public Health, Anhui Medical University, Hefei, People’s Republic of China
      name:Department of Medical Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of China
      name:Department of Medical Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(168)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.4s.

LINK . SPRINGER . COM {}